On January 27th, 2022, NCD Alliance Japan (Secretariat: Health and Global Policy Institute (HGPI)) held the second advisory board meeting of the Platform Project for Patient and Public Involvement.

At the meeting, we summarized the issues raised at the first Advisory Board meeting and discussed the steps that need to be taken to promote patient and public involvement.

To prevent the potential spread of Coronavirus Disease 2019 (COVID-19), this meeting was held remotely over an online conferencing system.

■ Overview
Date and time: Thursday , January 27, 2022; 18:00 – 19:30
Secretariat: Health and Global Policy Institute

[Program]

Opening remarks and project explanation

• Yuko Imamura (Manager, HGPI)

Summary of the first Advisory Board meeting

• Shotaro Tsukamoto (Associate, HGPI)

Discussion
Moderator

• Tomohito Shibata (Manager, HGPI)

Advisory board members (in no particular order; titles omitted)

• Kyoko Ama (Representative, Children and Healthcare Project; Fellow, HGPI)

  Shinsuke Amano (Chair, The Japan Federation of Cancer Patient Groups; CEO, Group Nexus Japan)

  Yoshiko Kobata (Director, CSR Promotion Office, General Affairs Bureau, Fuji Television Network, Inc.)

  Naomi Sakurai (President, Cancer Solutions Co., Ltd)

  Yasuhiro Sensho (CEO, SENSHO-GUMI, Co., Ltd.; Former Director-General, MHLW)

  Teppei Maeda (Lawyer, Maeda & Unosawa Law Offices; Representative, Medical Basic Act Community)

  Kaori Muto (Professor, Department of Public Policy Studies, Institute of Medical Science, University of Tokyo)

  Ikuko Yamaguchi (Chief Director, Consumer Organization for Medicine and Law (COML))

 Special advisor

• Yuji Inokuchi (Vice-President, Japan Medical Association)